Hematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation ConditioningGraft vs Host DiseaseHematopoietic Stem CellsHematologic NeoplasmsMyeloablative AgonistsTransplantation, AutologousWhole-Body IrradiationUnrelated DonorsGraft vs Tumor EffectTissue DonorsStem Cell TransplantationGraft vs Leukemia EffectBone Marrow TransplantationHistocompatibility TestingTransplantation ChimeraVidarabineTreatment OutcomeStem CellsPeripheral Blood Stem Cell TransplantationChimerismLeukemia, Myeloid, AcuteCord Blood Stem Cell TransplantationRetrospective StudiesRecurrenceLeukemiaBusulfanHistocompatibilityGraft SurvivalSiblingsDonor SelectionSurvival AnalysisMyelodysplastic SyndromesHLA AntigensMinor Histocompatibility AntigensRemission InductionImmunosuppressive AgentsSurvival RateHematologic DiseasesHematopoiesisDisease-Free SurvivalAllograftsPrecursor Cell Lymphoblastic Leukemia-LymphomaAcute DiseaseTime FactorsT-LymphocytesHematopoietic Stem Cell MobilizationGraft RejectionCombined Modality TherapyCyclosporineAntigens, CD34Bone Marrow CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFollow-Up StudiesLiver TransplantationCell DifferentiationImmunosuppressionLymphoma, Non-HodgkinCyclophosphamideMice, Inbred C57BLMycophenolic AcidCell LineageRisk FactorsLymphoproliferative DisordersCell TransplantationSalvage TherapyLiving DonorsLymphocyte DepletionLymphomaChronic DiseaseTacrolimusStem Cell NicheColony-Forming Units AssayFlow CytometryEmbryonic Stem CellsAdult Stem CellsFetal BloodTransplantation ImmunologyBone MarrowKidney TransplantationHematopoietic SystemAntineoplastic AgentsPrognosisMesenchymal Stem Cell TransplantationCells, CulturedMultiple MyelomaAge FactorsCytomegalovirus InfectionsCohort StudiesTransplantationStem Cell FactorCell SeparationCD8-Positive T-LymphocytesAnemia, AplasticMultipotent Stem CellsHepatic Veno-Occlusive DiseaseTransplantation, IsogeneicIncidencePluripotent Stem Cells